The guidance material, provided at no extra cost, is delivered via email alongside test results. It is designed to demystify the infection, offering insights into common contamination sources and setting realistic expectations for the recovery process. While the resource covers the "why" behind lingering symptoms after treatment, the company emphasizes that it does not replace professional medical intervention. It explicitly avoids providing dosing instructions or self-treatment protocols, directing users instead to consult with a licensed clinician.
Madison Ordway, an FDN-P who reviews the company's educational content, noted that the primary goal is to ensure patients arrive at their follow-up appointments prepared. By providing plain-language explanations of the qPCR-based findings—which detect specific DNA sequences—the service aims to make the time between receiving a result and seeing a doctor more productive. The resource is available exclusively to those who purchased their GI-MAP test directly through the company's platform, excluding tests ordered via third-party clinics or practitioners.

Comments (0)
No comments yet. Be the first!